Cabotegravir Sodium
98%
- Product Code: 107997
CAS:
1051375-13-3
| Molecular Weight: | 428.34 g./mol | Molecular Formula: | C₁₉H₁₇F₂N₃NaO₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Cabotegravir sodium is primarily used in the prevention and treatment of HIV-1 infection. It is a long-acting integrase strand transfer inhibitor (INSTI) administered as an injectable formulation, making it a convenient option for individuals who prefer not to take daily oral medications. This drug is often used in combination with rilpivirine as part of a complete regimen for maintaining viral suppression in adults who have achieved stable viral control. Its long-acting nature allows for monthly or bimonthly injections, reducing the burden of daily pill intake and improving adherence. Additionally, it is being explored for use in pre-exposure prophylaxis (PrEP) to prevent HIV infection in high-risk populations. The injectable form offers a discreet and effective alternative to traditional oral therapies, enhancing patient compliance and quality of life.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | $1,784.63 |
+
-
|
Cabotegravir Sodium
Cabotegravir sodium is primarily used in the prevention and treatment of HIV-1 infection. It is a long-acting integrase strand transfer inhibitor (INSTI) administered as an injectable formulation, making it a convenient option for individuals who prefer not to take daily oral medications. This drug is often used in combination with rilpivirine as part of a complete regimen for maintaining viral suppression in adults who have achieved stable viral control. Its long-acting nature allows for monthly or bimonthly injections, reducing the burden of daily pill intake and improving adherence. Additionally, it is being explored for use in pre-exposure prophylaxis (PrEP) to prevent HIV infection in high-risk populations. The injectable form offers a discreet and effective alternative to traditional oral therapies, enhancing patient compliance and quality of life.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :